Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis
Open Access
- 1 August 1997
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 350 (9077), 550-555
- https://doi.org/10.1016/s0140-6736(97)02342-8
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Temporal expression of the anabolic action of PTH in cancellous bone of ovariectomized ratsJournal of Bone and Mineral Research, 1996
- Report assessing vertebral fracturesJournal of Bone and Mineral Research, 1995
- Pathogenesis of osteoporosisThe Lancet, 1993
- An evaluation of several biochemical markers for bone formation and resorption in a protocol utilizing cyclical parathyroid hormone and calcitonin therapy for osteoporosis.Journal of Clinical Investigation, 1993
- Treatment of osteoporosis with human parathyroid peptide and observations on effect of sodium fluoride.BMJ, 1990
- Effect of Fluoride Treatment on the Fracture Rate in Postmenopausal Women with OsteoporosisNew England Journal of Medicine, 1990
- Resorption is not essential for the stimulation of bone growth by hPTH-(1-34) in rats in vivoJournal of Bone and Mineral Research, 1989
- NASAL CALCITONIN FOR TREATMENT OF ESTABLISHED OSTEOPOROSISClinical Endocrinology, 1989
- Effect of the Fluoride/Calcium Regimen on Vertebral Fracture Occurrence in Postmenopausal OsteoporosisNew England Journal of Medicine, 1982
- An evaluation of antibodies and clinical resistance to salmon calcitoninJournal of Clinical Investigation, 1972